山外山收盘上涨1.28%，滚动市盈率58.76倍，总市值43.28亿元

Core Insights - The company, Chongqing Shanwaishan Blood Purification Technology Co., Ltd., specializes in the research, production, and sales of blood purification equipment and consumables, as well as providing chain blood dialysis medical services [2] Financial Performance - For Q1 2025, the company reported a revenue of 189 million yuan, representing a year-on-year increase of 16.77% [2] - The net profit for the same period was 37.06 million yuan, showing a year-on-year growth of 8.10% [2] - The sales gross margin stood at 46.72% [2] Market Position - As of June 23, the company's stock closed at 13.47 yuan, with a 1.28% increase, resulting in a rolling price-to-earnings (PE) ratio of 58.76 times [1] - The total market capitalization of the company is 4.328 billion yuan [1] - In comparison to the industry, the average PE ratio for the medical device sector is 48.89 times, with a median of 35.79 times, placing the company at the 93rd position in the industry ranking [1][3] Shareholding Structure - As of Q1 2025, there are 8 institutions holding shares in the company, including 4 funds, with a total holding of 65.8456 million shares valued at 739 million yuan [1]